Study Overview
The primary objective of this research was to assess both subjective and objective measures of sleep among individuals diagnosed with functional neurological disorder (FND). This cross-sectional study involved gathering data from a sample population while comparing self-reported sleep patterns with objective data obtained through actigraphy, a method that tracks movement to infer sleep duration and quality.
Functional neurological disorder presents a unique challenge, given its complex interplay of neurological and psychological components. An understanding of sleep patterns in this population is crucial, as sleep disturbances are commonly reported by patients but may not align with objective measurements. The study aimed to bridge this gap and provide insights into the nature of sleep among those affected by FND.
To execute this study, a diverse sample of participants was recruited, ensuring a comprehensive assessment across various demographics. Detailed assessments incorporated multiple validated questionnaires targeting sleep quality, while the actigraphy provided objective data. This dual approach enabled a thorough examination of how patients perceive their sleep compared to actual sleep metrics collected over a specified period.
Moreover, the study sought to explore correlations between subjective reports and actigraphy results, uncovering potential discrepancies that could inform treatment strategies. A thorough analysis of these components aimed to enhance understanding of the overall health and well-being of individuals living with FND.
To synthesize the gathered data into understandable results, the findings are presented in an organized manner, illustrating key comparisons and highlighting essential trends detected throughout the research.
Methodology
The methodology of this study was designed to ensure a comprehensive and accurate analysis of sleep patterns in individuals diagnosed with functional neurological disorder (FND). The research employed a cross-sectional design that allowed the team to collect data from a diverse participant pool at a singular point in time, thus enabling a snapshot of sleep characteristics within this population.
Participants were recruited from both clinical settings and community outreach programs, emphasizing inclusivity across various demographics, including age, gender, and severity of FND symptoms. This recruitment strategy was critical to avoid selection bias and ensure that the findings would be generalizable to a broader population of individuals experiencing FND.
Each participant underwent a standardized assessment protocol, which included the completion of several validated questionnaires designed to evaluate self-reported sleep quality and patterns. Key tools employed in this study included the Pittsburgh Sleep Quality Index (PSQI), which assesses sleep quality over the past month, and the Epworth Sleepiness Scale (ESS) for measuring daytime sleepiness. These questionnaires help capture subjective perceptions of sleep, allowing researchers to gauge how individuals with FND view their own sleep experiences.
In addition to self-reports, actigraphy was utilized to provide objective sleep data. Participants were equipped with wrist-worn actigraphs that measured movement over a period of two consecutive weeks. These devices record activity levels, which can then be analyzed to estimate total sleep time, sleep efficiency, and the number of awakenings during the night. The use of actigraphy is particularly advantageous for studying sleep, as it allows for continuous monitoring in a naturalistic setting, thus avoiding the potential biases associated with laboratory sleep studies.
The collected data was then systematically analyzed using statistical software to identify correlations between subjective sleep quality reported by participants and the objective sleep metrics obtained from actigraphy. This analysis involved the use of Pearson correlation coefficients to quantify relationships between self-reported outcomes and actigraphic measures. Furthermore, demographic variables were controlled to better understand any influencing factors.
In summary, the study’s multifaceted methodology effectively combined subjective evaluations with objective monitoring to provide a robust analysis of sleep in the FND population, leading to rich data that could shape future clinical management strategies. A summary of participant demographics and key measures used in the analysis can be seen in the following table:
| Demographic Variable | Percentage |
|---|---|
| Female Participants | 65% |
| Age Range (Years) | 18-65 |
| Diagnosis Duration (Years) | Mean = 5.2 |
| PSQI Average Score | 8.4 |
| ESS Average Score | 10.1 |
Key Findings
The findings of this study reveal important insights into the sleep patterns of individuals with functional neurological disorder (FND). The data collected from self-reports and actigraphy provides a multifaceted view of how patients experience sleep and how those experiences compare with objective measurements. Notably, a substantial proportion of participants reported significant sleep disturbances despite varied actigraphic results.
Among the participants, a staggering 72% reported poor sleep quality, as assessed by the Pittsburgh Sleep Quality Index (PSQI). In contrast, actigraphy indicated that only 45% demonstrated objectively measured sleep disruptions like fragmented sleep or reduced sleep duration. This significant discrepancy raises questions about the reliability of self-reported sleep assessments in this population.
Furthermore, the actigraphy data revealed an average total sleep time of 6.2 hours per night, which is below the recommended range for most adults. Such findings were consistent with the high scores on the Epworth Sleepiness Scale (ESS), where participants exhibited moderate to high levels of daytime sleepiness, with an average score of 10.1. This suggests that even with markedly reduced total sleep time, individuals still struggle with excessive sleepiness during the day, potentially impacting their daily functioning.
A correlation analysis demonstrated that there was a significant negative relationship between PSQI and total sleep time measured by actigraphy (r = -0.48, p < 0.01). This indicates that as self-reported sleep quality worsened, the objectively measured sleep duration decreased. Conversely, no significant correlation was found between the ESS scores and actigraphic sleep measures, suggesting that while patients might feel excessively sleepy, their actual sleep metrics may not fully reflect this experience.
Additionally, subgroup analyses indicated that female participants reported poorer sleep quality compared to their male counterparts. The average PSQI score for females was 9.3, in contrast to 7.5 for males. This trend aligns with existing literature indicating a higher prevalence of sleep disorders among women, which could necessitate gender-specific interventions in clinical practice.
To encapsulate the findings, the table below summarizes key sleep metrics and self-reported measures that illustrate the study’s significant outcomes:
| Measurement | Self-Reported (Mean Score) | Actigraphy (Mean Value) |
|---|---|---|
| PSQI (Sleep Quality) | 8.4 | – |
| ESS (Daytime Sleepiness) | 10.1 | – |
| Total Sleep Time (Hours) | – | 6.2 |
| Sleep Efficiency (%) | – | 82% |
| Number of Awakenings | – | 3.5 |
These findings emphasize the need for clinicians to consider both subjective and objective assessments of sleep when addressing sleep issues among individuals with FND. The disconnect between self-reported and actigraphic data would suggest that patients might not fully understand the nature of their sleep disturbances, which could lead to mismanagement in treatment approaches.
Clinical Implications
Understanding the clinical implications of the discrepancies between subjective and objective sleep measures in individuals with functional neurological disorder (FND) is vital for enhancing patient care. The results of this study underscore the importance of integrating both self-reported assessments and objective measures into clinical practice, ultimately guiding more effective intervention strategies.
The substantial number of participants reporting poor sleep quality raises critical concerns regarding the management of sleep disturbances in FND. With 72% of individuals scoring poorly on the Pittsburgh Sleep Quality Index, it is evident that subjective perceptions of sleep heavily influence patients’ assessments of their well-being. This prevalent perception of inadequate sleep could correlate with broader health impacts, necessitating a multifaceted approach to treatment, including sleep hygiene education, cognitive behavioral therapy for insomnia (CBT-I), and addressing psychological comorbidities.
The notable gap between self-reported sleep disturbances and the actigraphic data highlights a potent area for clinical focus. Many patients may not accurately perceive their sleep quality or might downplay its significance, potentially leading healthcare providers to overlook sleep issues during assessments. These findings indicate an urgent need for clinicians to inquire about sleep patterns as part of their routine evaluations, utilizing both validated questionnaires and objective data collection methods to form a holistic view of the patient’s condition.
Furthermore, the significant negative correlation between self-reported sleep quality and total sleep time emphasizes that poor self-perception in sleep is associated with decreased sleep duration. This could lead to a cycle where inadequate sleep exacerbates FND symptoms, creating a compounding effect on patients’ overall health. Clinicians should consider implementing targeted interventions aimed at improving sleep quality, as enhancing sleep may lead to reductions in symptom severity and overall improvement in quality of life for individuals with FND.
The study’s findings also suggest the necessity of tailored interventions, particularly noting the gender differences in sleep quality. With female participants reporting poorer sleep outcomes, there may be a need for gender-specific therapeutic approaches taking into account the inherent biological and psychological differences that affect sleep. This could involve adjusting treatment plans to account for hormonal influences, social pressures, or differing coping strategies among genders, thereby enhancing the effectiveness of provided care.
Moreover, evidence of heightened daytime sleepiness among participants, combined with metric insights such as an average Epworth Sleepiness Scale score of 10.1, indicates that excessive daytime sleepiness should be addressed by clinicians. This symptom is not only uncomfortable but can severely hinder daily functioning and exacerbate FND-related challenges. Tailored recommendations such as structured sleep schedules, strategic napping, and lifestyle modifications may help alleviate daytime sleepiness, improving patient engagement in occupational and social activities.
The findings of this study present compelling evidence that sleep disturbances in individuals with FND require a nuanced approach in clinical settings. Healthcare providers must prioritize a dual assessment strategy, embrace the complexities of patient-reported outcomes, and address them within treatment frameworks, thus enabling more comprehensive care for individuals grappling with FND and sleep-related challenges.
